安徽医科大学学报
安徽醫科大學學報
안휘의과대학학보
ACTA UNIVERSITY MEDICINALIS ANHUI
2013年
11期
1336-1339
,共4页
盛敏玲%潘健%高婷%方益荣%张国庆%张志华%吴娟%郝加虎
盛敏玲%潘健%高婷%方益榮%張國慶%張誌華%吳娟%郝加虎
성민령%반건%고정%방익영%장국경%장지화%오연%학가호
乙型肝炎病毒%宫内感染%预防
乙型肝炎病毒%宮內感染%預防
을형간염병독%궁내감염%예방
hepatitis B virus%intrauterine infection%prevention
目的描述孕期乙型肝炎病毒(HBV)携带者和HBV宫内感染的新生儿HBV标志物的检测情况,分析孕期母体携带HBV与子代HBV宫内感染之间的关系,评估孕晚期注射乙肝免疫球蛋白预防新生儿HBV宫内感染的效果。方法在产前常规检查中,应用酶联免疫吸附试验检测合肥地区3415例孕妇的血清HBV标志物,将114例HBV携带孕妇作为研究对象;在孕妇产后采集新生儿脐带血,检测HBV标志物。采用字2检验分析孕期不同HBV感染状况和孕晚期是否注射乙肝免疫球蛋白与新生儿宫内感染 HBV之间的关系。结果共计检测了3415例孕妇,HBV携带率为3.34%(114/3415)。在112例HBV携带孕妇所分娩的112例活产新生儿中,有33例新生儿发生了HBV宫内感染,感染率为29.46%。3种常见的孕期HBV感染类型的孕妇其新生儿发生宫内HBV感染的发生率差异无统计学意义。有乙肝免疫球蛋白(HBIG)接种史的孕妇所分娩的新生儿HBV宫内感染发生率(13.16%)明显低于无HBIG接种史的孕妇所分娩的新生儿(37.83%),差异有统计学意义(X2=7.36, P<0.01)。结论合肥地区孕妇 HBV 携带率较低;孕妇HBeAg阳性可能是HBV宫内感染的危险因素;孕晚期注射HBIG能有效降低子代HBV宫内感染的发生率。
目的描述孕期乙型肝炎病毒(HBV)攜帶者和HBV宮內感染的新生兒HBV標誌物的檢測情況,分析孕期母體攜帶HBV與子代HBV宮內感染之間的關繫,評估孕晚期註射乙肝免疫毬蛋白預防新生兒HBV宮內感染的效果。方法在產前常規檢查中,應用酶聯免疫吸附試驗檢測閤肥地區3415例孕婦的血清HBV標誌物,將114例HBV攜帶孕婦作為研究對象;在孕婦產後採集新生兒臍帶血,檢測HBV標誌物。採用字2檢驗分析孕期不同HBV感染狀況和孕晚期是否註射乙肝免疫毬蛋白與新生兒宮內感染 HBV之間的關繫。結果共計檢測瞭3415例孕婦,HBV攜帶率為3.34%(114/3415)。在112例HBV攜帶孕婦所分娩的112例活產新生兒中,有33例新生兒髮生瞭HBV宮內感染,感染率為29.46%。3種常見的孕期HBV感染類型的孕婦其新生兒髮生宮內HBV感染的髮生率差異無統計學意義。有乙肝免疫毬蛋白(HBIG)接種史的孕婦所分娩的新生兒HBV宮內感染髮生率(13.16%)明顯低于無HBIG接種史的孕婦所分娩的新生兒(37.83%),差異有統計學意義(X2=7.36, P<0.01)。結論閤肥地區孕婦 HBV 攜帶率較低;孕婦HBeAg暘性可能是HBV宮內感染的危險因素;孕晚期註射HBIG能有效降低子代HBV宮內感染的髮生率。
목적묘술잉기을형간염병독(HBV)휴대자화HBV궁내감염적신생인HBV표지물적검측정황,분석잉기모체휴대HBV여자대HBV궁내감염지간적관계,평고잉만기주사을간면역구단백예방신생인HBV궁내감염적효과。방법재산전상규검사중,응용매련면역흡부시험검측합비지구3415례잉부적혈청HBV표지물,장114례HBV휴대잉부작위연구대상;재잉부산후채집신생인제대혈,검측HBV표지물。채용자2검험분석잉기불동HBV감염상황화잉만기시부주사을간면역구단백여신생인궁내감염 HBV지간적관계。결과공계검측료3415례잉부,HBV휴대솔위3.34%(114/3415)。재112례HBV휴대잉부소분면적112례활산신생인중,유33례신생인발생료HBV궁내감염,감염솔위29.46%。3충상견적잉기HBV감염류형적잉부기신생인발생궁내HBV감염적발생솔차이무통계학의의。유을간면역구단백(HBIG)접충사적잉부소분면적신생인HBV궁내감염발생솔(13.16%)명현저우무HBIG접충사적잉부소분면적신생인(37.83%),차이유통계학의의(X2=7.36, P<0.01)。결론합비지구잉부 HBV 휴대솔교저;잉부HBeAg양성가능시HBV궁내감염적위험인소;잉만기주사HBIG능유효강저자대HBV궁내감염적발생솔。
Objective To describe the prevalence of hepatitis B virus (HBV) carrier among pregnant women and HBV intrauterine infection in newborns. To examine the relationship between maternal HBV infection during preg-nancy and HBV intrauterine infection in newborns, and to evaluate the efficacy of hepatitis B immunoglobulin (HBIG) in interrupting HBV intrauterine infection during late pregnancy. Methods Before delivery, HBV sero-logical markers were tested by ELISA among 3 415 pregnant women under routine examination. Totally 114 preg-nant women with HBV were screened as target population. After delivery, umbilical bloods of neonates were tested. Chi-square test was used to compare the rate of HBV intrauterine infection in different groups. Results A total of 3 415 pregnant women from Hefei area were tested and HBV carrying rate was 3.34% (114/3 415). Among 112 neonates 33 were infected with HBV (29.46%). No significant difference was found among pregnant women with three types of common HBV infection. HBV intrauterine infection rate of neonates to mother with HBIG inoculation (13.16%) was significantly lower than those without HBIG inoculation (37.83%) (X2 =7.36, P<0.01). Con-clusion HBV carrying rate is low among pregnant women in Hefei. Positive maternal HBeAg is the risk factor of HBV intrauterine infection. HBV intrauterine infection can be interrupted effectively using HBIG during late preg-nancy.